Pretransplant imatinib can improve the outcome of nonmyeloablative stem cell transplantation without increasing the morbidity in Philadelphia chromosome-positive chronic myeloid leukemia.

Dong-Kee Kim,Yeun-Jun Chung,Lee S,Young-Yul Kim,Nak Gyun Chung,Jun Gi Kim,Il-Hoan Oh,Tai-Gyu Kim,Yoo-Li Kim,Hyun-Gyung Goh,Sung Hoon Kim,Byung-Sik Cho,Kim Hj,Chang-Ki Min,Junguee Lee,Jong Youl Jin,Chi Wha Han,Ji-Il Kim,Woo-Sung Min,Hyung Keun Kim,Chun Choo Kim

Pretransplant imatinib can improve the outcome of nonmyeloablative stem cell transplantation without increasing the morbidity in Philadelphia chromosome-positive chronic myeloid leukemia.

2004

Pretransplant imatinib can improve the outcome of nonmyeloablative stem cell transplantation without increasing the morbidity in Philadelphia chromosome-positive chronic myeloid leukemia

Keywords:

Cancer research
Stem cell
Philadelphia Chromosome Positive
Myeloid leukemia
Transplantation
Imatinib
Biology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations